Metfora has announced an award to pursue the detection of chronic diseases via multiplex analysis of circulating metabolites. The diagnostic technology was originally developed by College of Medicine – Tucson associate professors Ruslan Rafikov, PhD, and Olga Rafikova, MD, PhD.

The University of Arizona R. Ken Coit College of Pharmacy is hosting PharmTalk, an evening of brief lectures highlighting the clinicians and researchers working to create a healthier future.

Ivo Abraham, PhD, professor of practice in the R. Ken Coit College of Pharmacy, continues to examine how biosimilar guidelines from the World Health Organization have changed over time and how they view interchangeability and animal study requirements.

Despite a barrage of national headlines this past week, UArizona experts say the theory that the COVID-19 virus originated from a Chinese lab leak isn’t credible at this point. Felicia Goodrum, PhD, professor of immunobiology in the College of Medicine – Tucson, is quoted.

Due to recent cases and one known death, several agencies are issuing a warning regarding fentanyl found in cocaine. Steven Dudley, PharmD, DABAT, director of the Arizona Poison and Drug Information Center, is quoted.

A master’s program trains students to interpret and communicate genetic health information to help guide the treatment of patients and family members.

Eight local nonprofits will vie for more than $115,000 at the eighth annual "Fast Pitch Tucson" to be held March 30 at the UArizona Health Sciences Innovation Building.

The U.S. Preventive Services Task Force did not include people age 65 and older in its recommendation last year to screen adults for anxiety. The task force noted that questionnaires used to screen for anxiety may be unreliable for older adults.

The OPTIMUM study found that adding a medication, rather than switching medications, may help older adults with treatment-resistant depression.